Joshua S. Bauchner serves as the chair of the Cannabis and Psychedelics Practice Group and is a Partner in the Litigation and Bankruptcy practice groups. He brings a depth of expertise and dedication to the practice, where he is involved in complex commercial and securities litigation, class actions, and bankruptcy-related issues. His areas of specialization include:
- Enforcement of commercial contracts such as lease agreements, guaranties, purchase and sale contracts, and commission agreements.
- Litigation of partnership disputes.
- Defense against class actions stemming from alleged violations of consumer protection statutes.
- Addressing claims originating from insurance coverage denials.
- Defense against commercial foreclosure actions.
In the ever-evolving area of psychoactive substances, Josh was instrumental in co-hosting the inaugural Cannabis Symposium in New Jersey, attracting nearly a thousand attendees, with subsequent symposia continuing to garner attention. As a notable member of the New Jersey State Bar Association Cannabis Law Committee, the NORML Legal Committee, and the Amicus Committee, he received the New Jersey Law Journal’s Innovator of the Year Award.*
A passion for education and community development, as a licensed real estate instructor in New York, he educates aspiring real estate professionals, and he has served as an adjunct professor at Brooklyn Law School.
After graduating from law school, Josh had the honor of clerking for the Honorable Ursula Ungaro at the United States District Court for the Southern District of Florida. He also served as the Deputy Director of the Legal Division at the New York City Department of Consumer Affairs.
Josh is deeply involved in his community. He was appointed by the Manhattan Borough President to Manhattan Community Board 10, where he served as the Board’s treasurer and co-chaired the Committee on Land Use. Additionally, he has played an active role on the Board of Trustees for Wheaton College, the New York Theater Ballet, Frederick Douglass Boulevard Alliance, and the Harlem Wellness Center.
His extensive experience is also evident in representative matters, ranging from construction and design defect claims to defending corporate clients against securities fraud claims presented by the SEC and DOJ.
He is admitted to practice in both New York and New Jersey as well as the United States District Court of Michigan, The United States District Courts for the Southern, Eastern and Western Districts of New York, The United States District Court for the District of New Jersey as well as the United States Court of Appeals for the Second and Third Circuit.
In addition to his professional endeavors, Joshua’s thoughts and perspectives have been featured in numerous publications, shedding light on diverse areas such as cannabis laws, creditors’ rights in bankruptcy, and the intricacies of negligence claims.
*No aspect of this advertisement has been approved by the Supreme Court of New Jersey or the American Bar Association. A description of the standard or methodology used by the New Jersey Law Journal, can be found here.
New Jersey Law Journal’s Innovator of the Year Award
- New York Bar
- New Jersey Bar
- United States District Court for the Eastern District of Michigan
- United States District Court for the Southern District of New York
- United States District Court for the Eastern District of New York
- United States District Court for the Western District of New York
- United States District Court for the District of New Jersey
- United States Court of Appeals for the Second Circuit
- United States Court of Appeals for the Third Circuit
Brooklyn Law School, J.D., magna cum laude, 2001
Wheaton College, B.A., cum laude, 1995
From Vision to a Brooklyn Cannabis Business
November 28, 2023Our client, Kendall had a vision for a New York cannabis business, which she discussed during her estate planning sessions with Shawn McClelland from our Tax, Trusts, and Estates practice group. Recognizing the potential, Shawn introduced her to Joshua S. Bauchner, Chair of our Cannabis and Psychedelics Practice Group.
From Prohibition to Prosperity: Navigating Cannabis Legalization & Licensing in New Jersey
November 9, 2023In his latest video, Joshua Bauchner navigates the obstacles and triumphs along the path to cannabis legalization, with a particular focus on the State of New Jersey. He provides insights into the transition between administrations and how it has impacted the cannabis landscape in the state.
Struggling for Green Space – Unraveling Real Estate and Financing Challenges in the NJ Cannabis Industry
November 9, 2023At Mandelbaum Barrett PC, we specialize in a comprehensive analysis of the intricate challenges within the dynamic landscape of the cannabis industry in New Jersey and New York. Led by Joshua Bachner, Chair of the Cannabis and Psychedelics practice group at Mandelbaum Barrett PC, our team is ready to dissect the regulatory intricacies unique to the NJ/NY cannabis market.
Embracing Legal Cannabis: A Path to Safety, Wellness, and Universal Appeal
November 9, 2023Legal cannabis offers numerous advantages, ensuring consumers know exactly what they're getting and providing a safer alternative to the uncertainties of the black market. Joshua Bauchner, Chair of the Cannabis & Psychedelics practice group at Mandelbaum Barrett PC, delves into its popularity spanning various age groups, with older generations turning to cannabis to alleviate age-related ailments. Additionally, legal cannabis holds the potential to address the opioid crisis, promoting happier and healthier living when used responsibly.
From Stigma to Solution: Exploring Cannabis’s Untapped Potential and the Road to Federal Legalization
November 9, 2023Dive into the cannabis domain alongside Joshua Bauchner, Mandelbaum Barrett PC's Cannabis and Psychedelics practice group Chair. Hindered by federal constraints, cannabis's therapeutic potential has been obscured. Bauchner sheds light on the evolving landscape, revealing promising developments and foreseeing federal legalization within the decade, seeking to address past injustices.
From High Times to High Hopes: Advocating for Cannabis, Research, and Equity in the Garden State
November 3, 2023In recent years, Joshua Bauchner, chair of the Cannabis and Psychedelics Practice Group at Mandelbaum Barrett PC, has been advocating for cannabis reform in the United States. His journey into cannabis law began when he represented High Times magazine's board of directors, providing him with a unique perspective on the evolving cannabis and psychedelics industry. Bauchner has been instrumental in bringing cannabis awareness to the East Coast through annual symposiums, coinciding with Governor Murphy's promise to legalize cannabis in New Jersey.
New Jersey Cannabis Licensing Appeals: Seeking Fairness and Transparency
October 25, 2023In a pivotal legal battle that could shape the future of New Jersey's cannabis industry, the State's Appellate Division recently heard oral arguments for three consolidated appeals involving the 2019 Cannabis Licensing Request for Applications (RFA). The firm represented NJ Holistic Health, one of the appellants (A-001326-21), challenging the scoring of its application by the NJ Cannabis Regulatory Committee (CRC).
LAW 360: Mandelbaum Barrett PC Adds New Cannabis, Psychedelics Head
October 18, 2023Joshua Bauchner has joined Mandelbaum Barrett as a partner in the firm's litigation department, and will lead the growth of the cannabis and psychedelics team. He will be based in the firm's Roseland, New Jersey, office and will also work out of New York.
Joshua S. Bauchner Joins Mandelbaum Barrett PC as Chair of its Cannabis & Psychedelics Practice Group and Partner in its Litigation Practice Group
October 5, 2023Joshua S. Bauchner joined Mandelbaum Barrett PC as Chair of its expanded Cannabis & Psychedelics Practice Group and a Partner in its Litigation Practice Group. The firm also announced that it has renamed its Cannabis Practice as the Cannabis & Psychedelics Practice Group to reflect this growing, multifaceted and complex area of law that includes cannabis and psychedelics.